Fanapt
Product Images NDC 69189-0665

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fanapt (NDC 69189-0665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Iloperidone 4 mg Tablet (6918906651)

Medication label for Fanapt 4 mg tablet containing iloperidone. The label includes NDC 69189-0665 and identifies Avera McKennan Hospital in Sioux Falls, SD, as the labeler. The package appears to be for a single tablet with manufacturing and expiration details partially visible.*

FDA Label Image

Tablet Imprint (Fanapt Figure 01)

Fanapt (iloperidone) tablets open blister pack containing 14 yellow, capsule-shaped tablets arranged in two rows of seven. No additional labeling or dosage information visible. Labeler: Avera McKennan Hospital.*

FDA Label Image

Fanapt Structural Formula (Fanapt Figure 02)

Chemical structure diagram of the active ingredient for Fanapt, showing its molecular framework including fluorine, nitrogen, and oxygen atoms in a complex arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.